Illumina vs. Intuitive Surgical: Which Company Reported Better Earnings?
Illumina (NASDAQ: ILMN) and Intuitive Surgical (NASDAQ: ISRG) recently reported second-quarter earnings that were better than industry watchers' forecasts. These two game-changing healthcare companies could enjoy long-haul tailwinds, but they face different circumstances.
While Illumina is fending off competition and positioning itself to ride a wave of demand tied to personalized medicine, Intuitive Surgical is leveraging its installed base of robotic-surgery systems by developing new tools allowing its use in more procedures. Is one of these two companies executing on its strategy better than the other?
The ability to sequence genes is leading to incredible medical discoveries that are resulting in next-generation personalized medicine. At the forefront of gene sequencing is Illumina, a company that dominates the market for gene sequencers, with over 7,500 systems installed globally.
Source: Fool.com
Illumina Inc. Aktie
Die Community bevorzugt Illumina Inc., mit deutlich mehr Buy- (27) als Sell-Einschätzungen (4).
Ein Kursziel von 162 € für Illumina Inc. würde eine Steigerung von mehr als 50% gegenüber dem aktuellen Kurs von 107.86 € bedeuten.
